What are the implications and recommended next steps for a 54-year-old female with hemoglobin (Hb) of 15.8 and hematocrit (Hct) of 47.1?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 20, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Evaluation of Elevated Hemoglobin and Hematocrit in a 54-Year-Old Female

This 54-year-old female has borderline elevated hemoglobin (15.8 g/dL) and hematocrit (47.1%), which fall within the normal physiological range for healthy women but warrant confirmation with repeat testing and clinical correlation to exclude early erythrocytosis or secondary causes. 1

Understanding the Laboratory Values

Normal Reference Ranges:

  • For adult females, the typical hemoglobin range is 14.0 ± 2.0 g/dL and hematocrit is 41 ± 5% 2
  • The World Health Organization defines anemia in women ≥15 years as hemoglobin <12 g/dL 2
  • This patient's values (Hb 15.8 g/dL, Hct 47.1%) are at the upper end of normal but do not meet criteria for erythrocytosis 1

Erythrocytosis Thresholds:

  • True erythrocytosis in women is defined as hemoglobin >16.5 g/dL or hematocrit >49.5% 1
  • This patient falls just below these thresholds 1

Recommended Initial Approach

Confirm the Values:

  • Repeat hemoglobin and hematocrit measurements, as a single measurement is not reliable for establishing a diagnosis 1
  • If values remain stable and below erythrocytosis thresholds, serial monitoring every 3-6 months is appropriate 1

If Values Are Persistently Elevated or Rising:

Complete the initial laboratory workup: 1

  • Complete blood count with red cell indices (MCV, MCH, MCHC, RDW)
  • Reticulocyte count
  • Serum ferritin and transferrin saturation
  • C-reactive protein (CRP)

Key Diagnostic Considerations:

  1. Relative vs. Absolute Polycythemia:

    • Assess hydration status, as dehydration can cause hemoconcentration and falsely elevated values 1
    • Diuretic use can cause relative polycythemia through plasma volume depletion 1
  2. Secondary Causes to Evaluate: 1

    • Smoking history: Carbon monoxide exposure stimulates erythropoietin production causing "smoker's polycythemia" 1
    • Sleep apnea: Nocturnal hypoxemia drives erythropoietin production 1
    • Chronic lung disease: COPD or other pulmonary conditions causing chronic hypoxia 1
    • Medications: Testosterone therapy (even topical) can cause erythrocytosis 1
  3. Primary Polycythemia Vera (if values exceed thresholds):

    • JAK2 mutation testing (exon 14 and exon 12) should be performed if hemoglobin exceeds 16.5 g/dL or hematocrit exceeds 49.5% 1
    • Up to 97% of polycythemia vera cases carry JAK2 mutations 1

Age-Related Considerations

Important caveat: While some sources suggest hemoglobin may decline slightly with age in men, hemoglobin concentrations in women remain stable between ages 20-80 years 2

  • Anemia is not a normal consequence of aging and should always be investigated 2
  • The lowest acceptable hemoglobin level in women is 11.0 g/dL, regardless of age 3

When to Refer to Hematology

Immediate referral is indicated if: 1

  • JAK2 mutation is positive
  • Hemoglobin >20 g/dL or hematocrit >65% with symptoms of hyperviscosity
  • Unexplained splenomegaly
  • Associated thrombocytosis or leukocytosis suggesting myeloproliferative disorder

Common Pitfalls to Avoid

  • Do not assume these values are "normal for her" without excluding secondary causes 1
  • Do not perform therapeutic phlebotomy unless hemoglobin exceeds 20 g/dL and hematocrit exceeds 65% with hyperviscosity symptoms 1
  • Do not overlook coexisting iron deficiency, which can mask the degree of erythrocytosis 1
  • Hemoglobin is more reliable than hematocrit for monitoring, as hematocrit can falsely increase by 2-4% with prolonged sample storage 2

Practical Management Algorithm

For this specific patient (Hb 15.8, Hct 47.1):

  1. Repeat measurements in 1-2 months 1
  2. If stable and <16.5 g/dL hemoglobin: Monitor every 6 months 1
  3. If rising or exceeds 16.5 g/dL: Complete full workup including JAK2 testing 1
  4. Evaluate for secondary causes: smoking, sleep apnea, medications, chronic lung disease 1
  5. If all workup negative and values stable: Continue observation with annual monitoring 1

References

Guideline

Assessment Protocol for Incidental Erythrocytosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Laboratory values in the elderly. Are they different?

Emergency medicine clinics of North America, 1990

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.